- Home
- WIMI vs TPST Comparison
WIMI vs TPST Comparison
Compare WIMI & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WIMI
- TPST
- Stock Information
- Founded
- WIMI 2015
- TPST 2011
- Country
- WIMI China
- TPST United States
- Employees
- WIMI N/A
- TPST N/A
- Industry
- WIMI Computer Software: Prepackaged Software
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- WIMI Technology
- TPST Health Care
- Exchange
- WIMI Nasdaq
- TPST Nasdaq
- Market Cap
- WIMI 38.3M
- TPST 45.5M
- IPO Year
- WIMI 2020
- TPST N/A
- Fundamental
- Price
- WIMI $4.32
- TPST $9.92
- Analyst Decision
- WIMI
- TPST Hold
- Analyst Count
- WIMI 0
- TPST 3
- Target Price
- WIMI N/A
- TPST $30.00
- AVG Volume (30 Days)
- WIMI 199.2K
- TPST 60.6K
- Earning Date
- WIMI 01-01-0001
- TPST 11-11-2025
- Dividend Yield
- WIMI N/A
- TPST N/A
- EPS Growth
- WIMI N/A
- TPST N/A
- EPS
- WIMI 1.00
- TPST N/A
- Revenue
- WIMI $74,245,408.00
- TPST N/A
- Revenue This Year
- WIMI N/A
- TPST N/A
- Revenue Next Year
- WIMI N/A
- TPST N/A
- P/E Ratio
- WIMI $4.46
- TPST N/A
- Revenue Growth
- WIMI N/A
- TPST N/A
- 52 Week Low
- WIMI $2.24
- TPST $5.35
- 52 Week High
- WIMI $29.20
- TPST $20.67
- Technical
- Relative Strength Index (RSI)
- WIMI 59.42
- TPST 51.47
- Support Level
- WIMI $3.83
- TPST $9.90
- Resistance Level
- WIMI $4.07
- TPST $11.02
- Average True Range (ATR)
- WIMI 0.28
- TPST 0.66
- MACD
- WIMI 0.04
- TPST -0.14
- Stochastic Oscillator
- WIMI 81.23
- TPST 22.34
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.